Tag: autoimmune treatment market size

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Autoimmune Treatment Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The market for autoimmune disorder treatments has experienced significant expansion lately, with projections indicating a rise from $8.63 billion in 2025 to $9.84 billion in 2026, reflecting a compound annual growth rate of 14.0%. Key factors contributing to this upward trajectory during the past period include greater accessibility to immunosuppressive therapies, the broadening scope of rheumatology and immunology care, accumulating clinical expertise in managing autoimmune conditions, a higher incidence of patient diagnoses, and more comprehensive access to specialized pharmaceutical interventions.

The market for autoimmune treatments is poised for significant expansion. Projections indicate a market valuation of $16.53 billion by the year 2030, reflecting a compound annual growth rate of 13.9%. This upward trajectory is fueled by several key factors: heightened investment in innovative biologic treatments, a surge in the demand for individualized autoimmune therapy approaches, the broader implementation of digital tools for patient monitoring and ongoing care, a greater emphasis on mitigating the prolonged complications associated with these diseases, and intensified research efforts focused on regulating the immune system. During this projected period, several prominent trends are anticipated to shape the market landscape, including a greater embrace of biologic therapies, increased utilization of targeted immunomodulatory agents, deeper integration of chronic disease management initiatives, the wider adoption of customized treatment plans, and a stronger emphasis on the use of combination drug regimens.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7863&type=smp

Autoimmune Treatment Market Growth Drivers: What Factors Are Accelerating Expansion?

An upswing in spending on healthcare is anticipated to fuel the expansion of the autoimmune treatment sector. Healthcare spending encompasses all outlays related to health services, reproductive health initiatives, nutritional support, and urgent medical aid. Elevated levels of healthcare investment are likely to foster advancements in more potent treatments and medical innovations for autoimmune conditions. By way of illustration, projections from the UK’s Office for Budget Responsibility and Treasury suggest a rise in the nation’s health spending to £192 billion ($244.43 billion) for 2024/25, an increase from the £182 billion ($231.70 billion) recorded in 2022/23. Concurrently, data from the US-based National Health Expenditures Accounts via KFF reveals an expected 5% growth in American health expenditures between 2023 and 2024, reaching a total of $4.9 trillion. Consequently, augmented healthcare spending is a key factor propelling the autoimmune treatment market forward.

Autoimmune Treatment Market Segmentation And Category Breakdown

The autoimmune treatment market covered in this report is segmented –

1) By Service Type: Consultation And Diagnosis, Therapy And Monitoring, Drug development

2) By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases

3) By Application: Disease Management and Symptom Control, Disease Diagnosis and Monitoring, Immune Modulation and Targeted Therapy, Long-Term Care and Relapse Prevention

Subsegments:

1) By Consultation and Diagnosis: Clinical Evaluation and Medical Consultation, Autoimmune Biomarker Testing and Serological Assays, Imaging and Functional Diagnostic Services, Disease Severity Assessment and Risk Stratification

2) By Therapy and Monitoring: Pharmacological Treatment Management, Biologic and Immunotherapy Administration, Disease Activity Monitoring and Follow-Up Services, Adverse Event and Safety Monitoring, Patient Support and Adherence Programs

3) By Drug Development: Preclinical Research and Target Identification, Clinical Trial Services (Phase I–IV), Regulatory Affairs and Compliance Services, Pharmacovigilance and Post-Marketing Surveillance

Autoimmune Treatment Market Trends: What Is Shaping Future Industry Growth?

In the realm of autoimmune disease therapies, leading corporations are prioritizing the development of pioneering clinical trial frameworks to solidify their market standing. These cutting-edge platforms utilize sophisticated technological advancements and tailored methodologies to boost treatment effectiveness, bolster safety profiles, and improve patient results. A notable example occurred in August 2023 when the Scleroderma Research Foundation, a charitable organization based in the United States, unveiled the CONQUEST trial platform. This initiative is dedicated to accelerating research and therapeutic development for scleroderma, a rare autoimmune condition impacting connective tissues, while also tackling significant challenges in the clinical development process and facilitating progress in scleroderma treatments. The CONQUEST platform’s clinical trial represents a groundbreaking approach within the field of rare autoimmune diseases, engineered for the rapid assessment of prospective interventions for interstitial lung disease linked to systemic sclerosis (SSc-ILD), alongside comprehensive global SSc outcomes, encompassing aspects like skin involvement and other disease manifestations.

Autoimmune Treatment Market Competitive Analysis Of Major Industry Participants

Major companies operating in the autoimmune treatment market are Abbott Laboratories, Amgen Inc., Eli Lilly and Company, Pfizer Inc., F Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Biogen Idec Inc., GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Cabaletta Bio Inc., ChemoCentryx Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited

Access The Complete Autoimmune Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

Autoimmune Treatment Market Largest Region By Revenue And Market Share

North Americawas the largest region in the autoimmune treatment market in 2025. The regions covered in the autoimmune treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Autoimmune Treatment Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The market for autoimmune disorder treatments has experienced significant expansion lately, with projections indicating a rise from $8.63 billion in 2025 to $9.84 billion in 2026, reflecting a compound annual growth rate of 14.0%. Key factors contributing to this upward trajectory during the past period include greater accessibility to immunosuppressive therapies, the broadening scope of rheumatology and immunology care, accumulating clinical expertise in managing autoimmune conditions, a higher incidence of patient diagnoses, and more comprehensive access to specialized pharmaceutical interventions.

The market for autoimmune treatments is poised for significant expansion. Projections indicate a market valuation of $16.53 billion by the year 2030, reflecting a compound annual growth rate of 13.9%. This upward trajectory is fueled by several key factors: heightened investment in innovative biologic treatments, a surge in the demand for individualized autoimmune therapy approaches, the broader implementation of digital tools for patient monitoring and ongoing care, a greater emphasis on mitigating the prolonged complications associated with these diseases, and intensified research efforts focused on regulating the immune system. During this projected period, several prominent trends are anticipated to shape the market landscape, including a greater embrace of biologic therapies, increased utilization of targeted immunomodulatory agents, deeper integration of chronic disease management initiatives, the wider adoption of customized treatment plans, and a stronger emphasis on the use of combination drug regimens.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7863&type=smp

Autoimmune Treatment Market Growth Drivers: What Factors Are Accelerating Expansion?

An upswing in spending on healthcare is anticipated to fuel the expansion of the autoimmune treatment sector. Healthcare spending encompasses all outlays related to health services, reproductive health initiatives, nutritional support, and urgent medical aid. Elevated levels of healthcare investment are likely to foster advancements in more potent treatments and medical innovations for autoimmune conditions. By way of illustration, projections from the UK’s Office for Budget Responsibility and Treasury suggest a rise in the nation’s health spending to £192 billion ($244.43 billion) for 2024/25, an increase from the £182 billion ($231.70 billion) recorded in 2022/23. Concurrently, data from the US-based National Health Expenditures Accounts via KFF reveals an expected 5% growth in American health expenditures between 2023 and 2024, reaching a total of $4.9 trillion. Consequently, augmented healthcare spending is a key factor propelling the autoimmune treatment market forward.

Autoimmune Treatment Market Segmentation And Category Breakdown

The autoimmune treatment market covered in this report is segmented –

1) By Service Type: Consultation And Diagnosis, Therapy And Monitoring, Drug development

2) By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases

3) By Application: Disease Management and Symptom Control, Disease Diagnosis and Monitoring, Immune Modulation and Targeted Therapy, Long-Term Care and Relapse Prevention

Subsegments:

1) By Consultation and Diagnosis: Clinical Evaluation and Medical Consultation, Autoimmune Biomarker Testing and Serological Assays, Imaging and Functional Diagnostic Services, Disease Severity Assessment and Risk Stratification

2) By Therapy and Monitoring: Pharmacological Treatment Management, Biologic and Immunotherapy Administration, Disease Activity Monitoring and Follow-Up Services, Adverse Event and Safety Monitoring, Patient Support and Adherence Programs

3) By Drug Development: Preclinical Research and Target Identification, Clinical Trial Services (Phase I–IV), Regulatory Affairs and Compliance Services, Pharmacovigilance and Post-Marketing Surveillance

Autoimmune Treatment Market Trends: What Is Shaping Future Industry Growth?

In the realm of autoimmune disease therapies, leading corporations are prioritizing the development of pioneering clinical trial frameworks to solidify their market standing. These cutting-edge platforms utilize sophisticated technological advancements and tailored methodologies to boost treatment effectiveness, bolster safety profiles, and improve patient results. A notable example occurred in August 2023 when the Scleroderma Research Foundation, a charitable organization based in the United States, unveiled the CONQUEST trial platform. This initiative is dedicated to accelerating research and therapeutic development for scleroderma, a rare autoimmune condition impacting connective tissues, while also tackling significant challenges in the clinical development process and facilitating progress in scleroderma treatments. The CONQUEST platform’s clinical trial represents a groundbreaking approach within the field of rare autoimmune diseases, engineered for the rapid assessment of prospective interventions for interstitial lung disease linked to systemic sclerosis (SSc-ILD), alongside comprehensive global SSc outcomes, encompassing aspects like skin involvement and other disease manifestations.

Autoimmune Treatment Market Competitive Analysis Of Major Industry Participants

Major companies operating in the autoimmune treatment market are Abbott Laboratories, Amgen Inc., Eli Lilly and Company, Pfizer Inc., F Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Biogen Idec Inc., GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Cabaletta Bio Inc., ChemoCentryx Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited

Access The Complete Autoimmune Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

Autoimmune Treatment Market Largest Region By Revenue And Market Share

North Americawas the largest region in the autoimmune treatment market in 2025. The regions covered in the autoimmune treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Autoimmune Treatment Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The market for autoimmune disorder treatments has experienced significant expansion lately, with projections indicating a rise from $8.63 billion in 2025 to $9.84 billion in 2026, reflecting a compound annual growth rate of 14.0%. Key factors contributing to this upward trajectory during the past period include greater accessibility to immunosuppressive therapies, the broadening scope of rheumatology and immunology care, accumulating clinical expertise in managing autoimmune conditions, a higher incidence of patient diagnoses, and more comprehensive access to specialized pharmaceutical interventions.

The market for autoimmune treatments is poised for significant expansion. Projections indicate a market valuation of $16.53 billion by the year 2030, reflecting a compound annual growth rate of 13.9%. This upward trajectory is fueled by several key factors: heightened investment in innovative biologic treatments, a surge in the demand for individualized autoimmune therapy approaches, the broader implementation of digital tools for patient monitoring and ongoing care, a greater emphasis on mitigating the prolonged complications associated with these diseases, and intensified research efforts focused on regulating the immune system. During this projected period, several prominent trends are anticipated to shape the market landscape, including a greater embrace of biologic therapies, increased utilization of targeted immunomodulatory agents, deeper integration of chronic disease management initiatives, the wider adoption of customized treatment plans, and a stronger emphasis on the use of combination drug regimens.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7863&type=smp

Autoimmune Treatment Market Growth Drivers: What Factors Are Accelerating Expansion?

An upswing in spending on healthcare is anticipated to fuel the expansion of the autoimmune treatment sector. Healthcare spending encompasses all outlays related to health services, reproductive health initiatives, nutritional support, and urgent medical aid. Elevated levels of healthcare investment are likely to foster advancements in more potent treatments and medical innovations for autoimmune conditions. By way of illustration, projections from the UK’s Office for Budget Responsibility and Treasury suggest a rise in the nation’s health spending to £192 billion ($244.43 billion) for 2024/25, an increase from the £182 billion ($231.70 billion) recorded in 2022/23. Concurrently, data from the US-based National Health Expenditures Accounts via KFF reveals an expected 5% growth in American health expenditures between 2023 and 2024, reaching a total of $4.9 trillion. Consequently, augmented healthcare spending is a key factor propelling the autoimmune treatment market forward.

Autoimmune Treatment Market Segmentation And Category Breakdown

The autoimmune treatment market covered in this report is segmented –

1) By Service Type: Consultation And Diagnosis, Therapy And Monitoring, Drug development

2) By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases

3) By Application: Disease Management and Symptom Control, Disease Diagnosis and Monitoring, Immune Modulation and Targeted Therapy, Long-Term Care and Relapse Prevention

Subsegments:

1) By Consultation and Diagnosis: Clinical Evaluation and Medical Consultation, Autoimmune Biomarker Testing and Serological Assays, Imaging and Functional Diagnostic Services, Disease Severity Assessment and Risk Stratification

2) By Therapy and Monitoring: Pharmacological Treatment Management, Biologic and Immunotherapy Administration, Disease Activity Monitoring and Follow-Up Services, Adverse Event and Safety Monitoring, Patient Support and Adherence Programs

3) By Drug Development: Preclinical Research and Target Identification, Clinical Trial Services (Phase I–IV), Regulatory Affairs and Compliance Services, Pharmacovigilance and Post-Marketing Surveillance

Autoimmune Treatment Market Trends: What Is Shaping Future Industry Growth?

In the realm of autoimmune disease therapies, leading corporations are prioritizing the development of pioneering clinical trial frameworks to solidify their market standing. These cutting-edge platforms utilize sophisticated technological advancements and tailored methodologies to boost treatment effectiveness, bolster safety profiles, and improve patient results. A notable example occurred in August 2023 when the Scleroderma Research Foundation, a charitable organization based in the United States, unveiled the CONQUEST trial platform. This initiative is dedicated to accelerating research and therapeutic development for scleroderma, a rare autoimmune condition impacting connective tissues, while also tackling significant challenges in the clinical development process and facilitating progress in scleroderma treatments. The CONQUEST platform’s clinical trial represents a groundbreaking approach within the field of rare autoimmune diseases, engineered for the rapid assessment of prospective interventions for interstitial lung disease linked to systemic sclerosis (SSc-ILD), alongside comprehensive global SSc outcomes, encompassing aspects like skin involvement and other disease manifestations.

Autoimmune Treatment Market Competitive Analysis Of Major Industry Participants

Major companies operating in the autoimmune treatment market are Abbott Laboratories, Amgen Inc., Eli Lilly and Company, Pfizer Inc., F Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Biogen Idec Inc., GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Cabaletta Bio Inc., ChemoCentryx Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited

Access The Complete Autoimmune Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

Autoimmune Treatment Market Largest Region By Revenue And Market Share

North Americawas the largest region in the autoimmune treatment market in 2025. The regions covered in the autoimmune treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Forecasted Market Size Of The Autoimmune Treatment Market Compare Between 2026 And 2030?

The autoimmune treatment market has witnessed considerable expansion in recent years. This market is expected to grow from $8.63 billion in 2025 to $9.84 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.0%. Historically, this growth was primarily driven by improved availability of immunosuppressive drugs, the expansion of rheumatology and immunology services, an increase in clinical experience concerning autoimmune care, higher patient diagnosis rates, and broader access to specialty medications.

The autoimmune treatment market is projected to experience substantial expansion in the coming years, with its size reaching $16.53 billion by 2030, driven by a compound annual growth rate (CAGR) of 13.9%. This anticipated growth is primarily attributable to factors such as increasing investment in novel biologics development, an escalating demand for personalized autoimmune therapies, the expansion of digital monitoring and follow-up care, a heightened emphasis on reducing long-term disease complications, and increased research into immune system modulation. Key developments expected during this period include the increasing adoption of biologic therapies, a surge in the use of targeted immunomodulators, the broader integration of long-term disease management programs, the proliferation of personalized treatment regimens, and an enhanced focus on combination drug therapies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7863&type=smp

Which Growth Factors Are Strengthening The Autoimmune Treatment Market Landscape?

The expansion of the autoimmune treatment market is expected to be driven by the escalating healthcare expenditures. These expenditures cover all expenses linked to delivering health services, initiatives for family planning, nutritional programs, and urgent medical aid, all focused on health. A surge in healthcare spending would pave the way for the development of more effective treatments and advanced medical technologies for autoimmune conditions. For instance, projections from the Office for Budget Responsibility (OBR) and Treasury show that the UK’s anticipated health expenditure is set to climb to £192 billion ($244.43 billion) in 2024/25, an increase from £182 billion ($231.70 billion) in 2022/23. Similarly, the National Health Expenditures Accounts (NHEA) from KFF, a US-based independent health policy research organization, indicates that health spending in the United States is projected to grow by 5% from 2023 to 2024, reaching $4.9 trillion. Therefore, the upward trend in healthcare expenditures is a key factor propelling the growth of the autoimmune treatment market.

How Is The Autoimmune Treatment Market Examined Through Segment Analysis?

The autoimmune treatment market covered in this report is segmented –

1) By Service Type: Consultation And Diagnosis, Therapy And Monitoring, Drug development

2) By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases

3) By Application: Disease Management and Symptom Control, Disease Diagnosis and Monitoring, Immune Modulation and Targeted Therapy, Long-Term Care and Relapse Prevention

Subsegments:

1) By Consultation and Diagnosis: Clinical Evaluation and Medical Consultation, Autoimmune Biomarker Testing and Serological Assays, Imaging and Functional Diagnostic Services, Disease Severity Assessment and Risk Stratification

2) By Therapy and Monitoring: Pharmacological Treatment Management, Biologic and Immunotherapy Administration, Disease Activity Monitoring and Follow-Up Services, Adverse Event and Safety Monitoring, Patient Support and Adherence Programs

3) By Drug Development: Preclinical Research and Target Identification, Clinical Trial Services (Phase I–IV), Regulatory Affairs and Compliance Services, Pharmacovigilance and Post-Marketing Surveillance

Which Trends Are Influencing The Expansion Of The Autoimmune Treatment Market?

Leading companies in the autoimmune treatment market are increasingly concentrating on implementing advanced clinical trial platforms to secure a competitive edge. These pioneering clinical trial platforms in autoimmune treatment employ sophisticated technologies and individualized strategies to boost effectiveness, safety, and patient results. For example, in August 2023, the Scleroderma Research Foundation, a US-based non-profit organization, unveiled the CONQUEST trial platform. The CONQUEST program is dedicated to advancing research and developing treatments for scleroderma, a rare autoimmune disease affecting connective tissues. It addresses significant challenges in clinical development and supports progress in scleroderma therapeutics. The CONQUEST platform clinical trial marks a first in rare autoimmune diseases, specifically engineered to swiftly assess potential treatments for interstitial lung disease associated with systemic sclerosis (SSc-ILD) and overall SSc outcomes, encompassing those related to skin and other facets of the illness.

Who Are The Businesses Driving Activity In The Autoimmune Treatment Market?

Major companies operating in the autoimmune treatment market are Abbott Laboratories, Amgen Inc., Eli Lilly and Company, Pfizer Inc., F Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Biogen Idec Inc., GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Cabaletta Bio Inc., ChemoCentryx Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited

Access The Complete Autoimmune Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

Which Region Has The Strongest Presence In The Autoimmune Treatment Market?

North America was the largest region in the autoimmune treatment market in 2025. The regions covered in the autoimmune treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Autoimmune Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=7863&type=smp

Browse Through More Reports Similar to the Global Autoimmune Treatment Market 2026, By The Business Research Company

Autoimmune Disease Diagnosis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Veterinary Autoimmune Disease Therapeutics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-autoimmune-disease-therapeutics-global-market-report

Systemic Lupus Erythematosus Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/systemic-lupus-erythematosus-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Forecasted Market Size Of The Autoimmune Treatment Market Compare Between 2026 And 2030?

The autoimmune treatment market has witnessed considerable expansion in recent years. This market is expected to grow from $8.63 billion in 2025 to $9.84 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.0%. Historically, this growth was primarily driven by improved availability of immunosuppressive drugs, the expansion of rheumatology and immunology services, an increase in clinical experience concerning autoimmune care, higher patient diagnosis rates, and broader access to specialty medications.

The autoimmune treatment market is projected to experience substantial expansion in the coming years, with its size reaching $16.53 billion by 2030, driven by a compound annual growth rate (CAGR) of 13.9%. This anticipated growth is primarily attributable to factors such as increasing investment in novel biologics development, an escalating demand for personalized autoimmune therapies, the expansion of digital monitoring and follow-up care, a heightened emphasis on reducing long-term disease complications, and increased research into immune system modulation. Key developments expected during this period include the increasing adoption of biologic therapies, a surge in the use of targeted immunomodulators, the broader integration of long-term disease management programs, the proliferation of personalized treatment regimens, and an enhanced focus on combination drug therapies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7863&type=smp

Which Growth Factors Are Strengthening The Autoimmune Treatment Market Landscape?

The expansion of the autoimmune treatment market is expected to be driven by the escalating healthcare expenditures. These expenditures cover all expenses linked to delivering health services, initiatives for family planning, nutritional programs, and urgent medical aid, all focused on health. A surge in healthcare spending would pave the way for the development of more effective treatments and advanced medical technologies for autoimmune conditions. For instance, projections from the Office for Budget Responsibility (OBR) and Treasury show that the UK’s anticipated health expenditure is set to climb to £192 billion ($244.43 billion) in 2024/25, an increase from £182 billion ($231.70 billion) in 2022/23. Similarly, the National Health Expenditures Accounts (NHEA) from KFF, a US-based independent health policy research organization, indicates that health spending in the United States is projected to grow by 5% from 2023 to 2024, reaching $4.9 trillion. Therefore, the upward trend in healthcare expenditures is a key factor propelling the growth of the autoimmune treatment market.

How Is The Autoimmune Treatment Market Examined Through Segment Analysis?

The autoimmune treatment market covered in this report is segmented –

1) By Service Type: Consultation And Diagnosis, Therapy And Monitoring, Drug development

2) By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases

3) By Application: Disease Management and Symptom Control, Disease Diagnosis and Monitoring, Immune Modulation and Targeted Therapy, Long-Term Care and Relapse Prevention

Subsegments:

1) By Consultation and Diagnosis: Clinical Evaluation and Medical Consultation, Autoimmune Biomarker Testing and Serological Assays, Imaging and Functional Diagnostic Services, Disease Severity Assessment and Risk Stratification

2) By Therapy and Monitoring: Pharmacological Treatment Management, Biologic and Immunotherapy Administration, Disease Activity Monitoring and Follow-Up Services, Adverse Event and Safety Monitoring, Patient Support and Adherence Programs

3) By Drug Development: Preclinical Research and Target Identification, Clinical Trial Services (Phase I–IV), Regulatory Affairs and Compliance Services, Pharmacovigilance and Post-Marketing Surveillance

Which Trends Are Influencing The Expansion Of The Autoimmune Treatment Market?

Leading companies in the autoimmune treatment market are increasingly concentrating on implementing advanced clinical trial platforms to secure a competitive edge. These pioneering clinical trial platforms in autoimmune treatment employ sophisticated technologies and individualized strategies to boost effectiveness, safety, and patient results. For example, in August 2023, the Scleroderma Research Foundation, a US-based non-profit organization, unveiled the CONQUEST trial platform. The CONQUEST program is dedicated to advancing research and developing treatments for scleroderma, a rare autoimmune disease affecting connective tissues. It addresses significant challenges in clinical development and supports progress in scleroderma therapeutics. The CONQUEST platform clinical trial marks a first in rare autoimmune diseases, specifically engineered to swiftly assess potential treatments for interstitial lung disease associated with systemic sclerosis (SSc-ILD) and overall SSc outcomes, encompassing those related to skin and other facets of the illness.

Who Are The Businesses Driving Activity In The Autoimmune Treatment Market?

Major companies operating in the autoimmune treatment market are Abbott Laboratories, Amgen Inc., Eli Lilly and Company, Pfizer Inc., F Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Biogen Idec Inc., GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Cabaletta Bio Inc., ChemoCentryx Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited

Access The Complete Autoimmune Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

Which Region Has The Strongest Presence In The Autoimmune Treatment Market?

North America was the largest region in the autoimmune treatment market in 2025. The regions covered in the autoimmune treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Autoimmune Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=7863&type=smp

Browse Through More Reports Similar to the Global Autoimmune Treatment Market 2026, By The Business Research Company

Autoimmune Disease Diagnosis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Veterinary Autoimmune Disease Therapeutics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-autoimmune-disease-therapeutics-global-market-report

Systemic Lupus Erythematosus Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/systemic-lupus-erythematosus-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Autoimmune Treatment Market Projected To Reach By 2030?

The autoimmune treatment market size has experienced rapid expansion in recent years. This market is projected to expand from $8.63 billion in 2025 to $9.84 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.0%. Historically, this growth has been driven by factors such as the enhanced availability of immunosuppressive drugs, the broadening of rheumatology and immunology services, increasing clinical expertise in autoimmune care, higher patient diagnosis rates, and expanded access to specialty medications.

The autoimmune treatment market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $16.53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.9%. Factors contributing to this growth during the projection period include heightened investment in the development of novel biologics, an increasing need for personalized autoimmune therapies, the broadened availability of digital monitoring and follow-up care, an intensified focus on mitigating long-term disease complications, and augmented research into immune system modulation. Key trends identified for the forecast period encompass the wider adoption of biologic therapies, a greater utilization of targeted immunomodulators, the increasing incorporation of long-term disease management programs, an expansion of personalized treatment regimens, and an elevated emphasis on combination drug therapies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

What Key Drivers Are Fueling The Growth Of The Autoimmune Treatment Market?

The expansion of healthcare expenditures is anticipated to boost the autoimmune treatment market. These expenditures encompass all costs related to providing health services, family planning, nutrition programs, and health-oriented emergency assistance. An increase in healthcare spending would facilitate the creation of more effective therapies and advanced medical technologies for autoimmune conditions. For example, forecasts from the Office for Budget Responsibility (OBR) and Treasury project the UK’s planned health expenditure to climb to £192 billion ($244.43 billion) in 2024/25, an increase from £182 billion ($231.70 billion) in 2022/23. Concurrently, data from the National Health Expenditures Accounts (NHEA), compiled by KFF, a US-based independent health policy research organization, indicates that health spending in the United States is predicted to grow by 5% from 2023 to 2024, reaching $4.9 trillion. Consequently, the growth in healthcare expenditures is a key driver for the autoimmune treatment market.

What Are The Main Segments Within The Autoimmune Treatment Market Segment Structure?

The autoimmune treatment market covered in this report is segmented –

1) By Service Type: Consultation And Diagnosis, Therapy And Monitoring, Drug development

2) By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases

3) By Application: Disease Management and Symptom Control, Disease Diagnosis and Monitoring, Immune Modulation and Targeted Therapy, Long-Term Care and Relapse Prevention

Subsegments:

1) By Consultation and Diagnosis: Clinical Evaluation and Medical Consultation, Autoimmune Biomarker Testing and Serological Assays, Imaging and Functional Diagnostic Services, Disease Severity Assessment and Risk Stratification

2) By Therapy and Monitoring: Pharmacological Treatment Management, Biologic and Immunotherapy Administration, Disease Activity Monitoring and Follow-Up Services, Adverse Event and Safety Monitoring, Patient Support and Adherence Programs

3) By Drug Development: Preclinical Research and Target Identification, Clinical Trial Services (Phase I–IV), Regulatory Affairs and Compliance Services, Pharmacovigilance and Post-Marketing Surveillance

What Trends Are Influencing The Autoimmune Treatment Market?

Leading entities within the autoimmune treatment market are intensifying efforts to launch advanced clinical trial platforms, aiming for a competitive advantage. These cutting-edge platforms in autoimmune treatment utilize sophisticated technologies and tailored strategies to improve effectiveness, safety, and results for patients. An example of this is the Scleroderma Research Foundation, a US-based non-profit organization, which introduced the CONQUEST trial platform in August 2023. The objective of the CONQUEST program is to further research and therapeutic options for scleroderma, a rare autoimmune condition impacting connective tissues. This initiative tackles crucial challenges in clinical development, facilitating progress in scleroderma treatments. Unique among rare autoimmune diseases, the CONQUEST platform clinical trial is structured to rapidly assess prospective therapies for interstitial lung disease associated with systemic sclerosis (SSc-ILD), alongside overall SSc outcomes, encompassing those related to skin and various other disease facets.

Who Are The Companies Participating In The Autoimmune Treatment Market?

Major companies operating in the autoimmune treatment market are Abbott Laboratories, Amgen Inc., Eli Lilly and Company, Pfizer Inc., F Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Biogen Idec Inc., GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Cabaletta Bio Inc., ChemoCentryx Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited

Get The Full Autoimmune Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

Which Region Has The Greatest Market Share In The Autoimmune Treatment Market?

North America was the largest region in the autoimmune treatment market in 2025. The regions covered in the autoimmune treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Autoimmune Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

Browse Through More Reports Similar to the Global Autoimmune Treatment Market 2026, By The Business Research Company

Systemic Lupus Erythematosus Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/systemic-lupus-erythematosus-treatment-global-market-report

Autoimmune Disease Diagnosis Market Report 2026

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Veterinary Autoimmune Disease Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-autoimmune-disease-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Autoimmune Treatment Market In 2026 And What Value Is Projected For 2030?

The autoimmune treatment market size has seen rapid growth in recent years. It is anticipated to expand from $8.63 billion in 2025 to $9.84 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.0%. The expansion observed in prior periods can be attributed to improved accessibility of immunosuppressive drugs, the development of rheumatology and immunology services, an increase in clinical experience concerning autoimmune care, higher rates of patient diagnosis, and more extensive access to specialty medications.

The autoimmune treatment market size is anticipated to experience swift expansion in the upcoming years. It is projected to reach $16.53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.9%. This projected growth can be attributed to increased investment in developing novel biologics, a rising demand for tailored autoimmune therapies, the broadening of digital monitoring and follow-up care services, an intensified focus on reducing long-term disease complications, and augmented research into immune system modulation. Significant trends expected during this forecast period involve a greater adoption of biologic therapies, an increasing utilization of targeted immunomodulators, the growing integration of long-term disease management programs, an expansion of personalized treatment regimens, and an enhanced focus on combination drug therapies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7863&type=smp

What Key Drivers Are Influencing The Growth Of The Autoimmune Treatment Market?

The anticipated increase in healthcare spending is set to stimulate expansion within the autoimmune treatment market in the future. Healthcare expenditures encompass all expenses linked to delivering health services, family planning initiatives, nutritional schemes, and health-focused emergency assistance. An uptick in healthcare spending is projected to foster the creation of improved therapies and advanced medical technologies specifically for autoimmune conditions. For example, projections from the Office for Budget Responsibility (OBR) and Treasury indicate that the UK’s planned health expenditure is forecasted to climb to £192 billion ($244.43 billion) in 2024/25, rising from £182 billion ($231.70 billion) recorded in 2022/23. Likewise, data from the National Health Expenditures Accounts (NHEA) by KFF, an independent health policy research organization based in the US, suggests that health spending in the United States is expected to expand by 5% from 2023 to 2024, eventually reaching $4.9 trillion. Consequently, the increase in healthcare expenditures is a key impetus behind the expansion of the autoimmune treatment market.

What Are The Key Segments Of The Autoimmune Treatment Market?

The autoimmune treatment market covered in this report is segmented –

1) By Service Type: Consultation And Diagnosis, Therapy And Monitoring, Drug development

2) By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases

3) By Application: Disease Management and Symptom Control, Disease Diagnosis and Monitoring, Immune Modulation and Targeted Therapy, Long-Term Care and Relapse Prevention

Subsegments:

1) By Consultation and Diagnosis: Clinical Evaluation and Medical Consultation, Autoimmune Biomarker Testing and Serological Assays, Imaging and Functional Diagnostic Services, Disease Severity Assessment and Risk Stratification

2) By Therapy and Monitoring: Pharmacological Treatment Management, Biologic and Immunotherapy Administration, Disease Activity Monitoring and Follow-Up Services, Adverse Event and Safety Monitoring, Patient Support and Adherence Programs

3) By Drug Development: Preclinical Research and Target Identification, Clinical Trial Services (Phase I–IV), Regulatory Affairs and Compliance Services, Pharmacovigilance and Post-Marketing Surveillance

Which Market Trends Are Creating New Opportunities In The Autoimmune Treatment Market?

Major companies operating in the autoimmune treatment market are increasing their emphasis on introducing innovative clinical trial platforms to gain a competitive advantage. These novel clinical trial platforms in autoimmune treatment leverage advanced technologies and personalized methods to enhance efficacy, safety, and patient outcomes. For instance, in August 2023, the Scleroderma Research Foundation, a US-based non-profit organization, launched the CONQUEST trial platform. The CONQUEST program aims to advance research and treatments for scleroderma, a rare autoimmune disease that affects connective tissues. It addresses critical issues in clinical development and facilitates advancements in scleroderma therapeutics. The CONQUEST platform clinical trial is the first of its kind in rare autoimmune diseases, designed to quickly evaluate potential treatments for interstitial lung disease associated with systemic sclerosis (SSc-ILD), as well as global SSc outcomes, including those focused on skin and other aspects of the disease.

Who Are The Leading Companies Operating In The Autoimmune Treatment Market?

Major companies operating in the autoimmune treatment market are Abbott Laboratories, Amgen Inc., Eli Lilly and Company, Pfizer Inc., F Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Biogen Idec Inc., GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Cabaletta Bio Inc., ChemoCentryx Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited

Read the full autoimmune treatment market report here:

https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Autoimmune Treatment Market?

North America was the largest region in the autoimmune treatment market in 2025. The regions covered in the autoimmune treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Autoimmune Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7863&type=smp

Browse Through More Reports Similar to the Global Autoimmune Treatment Market 2026, By The Business Research Company

Autoimmune Disease Diagnosis Global Market Report

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Veterinary Autoimmune Disease Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/veterinary-autoimmune-disease-therapeutics-global-market-report

Systemic Lupus Erythematosus Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/systemic-lupus-erythematosus-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model